ORBIMED ADVISORS LLC Q1 2021 Filing
Filed May 17, 2021
Portfolio Value
$10.7B
Holdings
155
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (155 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | 290ACHINOOK THERAPEUTICS INC | 1,250,001 | $19.4B | 181.63% | |
| 102 | JNCEEURJOUNCE THERAPEUTICS INC | 1,823,600 | $18.7B | 175.11% | |
| 103 | GILDGILEAD SCIENCES INC | 287,600 | $18.6B | 173.80% | |
| 104 | VTGNUSDVISTAGEN THERAPEUTICS INC | 8,604,000 | $18.3B | 171.36% | |
| 105 | GLPGGALAPAGOS NV | 230,905 | $17.8B | 166.43% | |
| 106 | ALHCALIGNMENT HEALTHCARE INC | 800,000 | $17.5B | 164.04% | |
| 107 | PHGEBIOMX INC | 2,313,489 | $16.5B | 154.02% | |
| 108 | BLUBELLUS HEALTH INC NEW | 3,954,800 | $15.1B | 141.19% | |
| 109 | MISTMILESTONE PHARMACEUTICALS IN | 2,583,821 | $15.0B | 139.88% | |
| 110 | SRPTSAREPTA THERAPEUTICS INC | 200,278 | $14.9B | 139.57% | |
| 111 | —SYROS PHARMACEUTICALS INC | 1,837,500 | $13.7B | 128.52% | |
| 112 | TVTXTRAVERE THERAPEUTICS INC | 528,100 | $13.2B | 123.30% | |
| 113 | —SILVER SPIKE ACQUISITION COR | 700,400 | $12.9B | 120.23% | |
| 114 | PCVXVAXCYTE INC | 648,774 | $12.8B | 119.80% | |
| 115 | ALECALECTOR INC | 611,478 | $12.3B | 115.15% | |
| 116 | RLAYRELAY THERAPEUTICS INC | 350,000 | $12.1B | 113.14% | |
| 117 | ASNSUSDX4 PHARMACEUTICALS INC | 1,373,849 | $11.8B | 110.60% | |
| 118 | —MAGENTA THERAPEUTICS INC | 949,048 | $11.2B | 105.07% | |
| 119 | ALXOALX ONCOLOGY HLDGS INC | 150,000 | $11.1B | 103.42% | |
| 120 | —ONCOCYTE CORP | 2,100,000 | $10.9B | 101.91% | |
| 121 | —OLINK HLDG AB | 300,000 | $10.8B | 100.98% | |
| 122 | GYRECATALYST BIOSCIENCES INC | 2,118,600 | $10.7B | 99.84% | |
| 123 | NRIXNURIX THERAPEUTICS INC | 300,000 | $9.3B | 87.21% | |
| 124 | LRMRLARIMAR THERAPEUTICS INC | 617,245 | $9.0B | 84.32% | |
| 125 | —ASLAN PHARMACEUTICALS LTD | 2,520,000 | $8.4B | 78.93% | |
| 126 | HCATHEALTH CATALYST INC | 179,598 | $8.4B | 78.54% | |
| 127 | NUVBNUVATION BIO INC | 800,000 | $8.4B | 78.17% | |
| 128 | OTICEUROTONOMY INC | 3,250,000 | $8.3B | 77.49% | |
| 129 | STROSUTRO BIOPHARMA INC | 350,000 | $8.0B | 74.48% | |
| 130 | NBTXNANOBIOTIX SA | 500,000 | $7.5B | 70.31% | |
| 131 | —SYNLOGIC INC | 2,029,996 | $7.3B | 67.95% | |
| 132 | TARAPROTARA THERAPEUTICS INC | 450,000 | $7.1B | 66.23% | |
| 133 | —AERPIO PHARMACEUTICALS INC | 5,193,946 | $6.7B | 62.65% | |
| 134 | SGFYGBPSIGNIFY HEALTH INC | 225,000 | $6.6B | 61.56% | |
| 135 | —LANDOS BIOPHARMA INC | 681,000 | $6.6B | 61.32% | |
| 136 | NTLAINTELLIA THERAPEUTICS INC | 72,500 | $5.8B | 54.40% | |
| 137 | LUNGPULMONX CORP | 125,000 | $5.7B | 53.46% | |
| 138 | —HEALTH SCIENCES ACQ CORP 2 | 500,000 | $5.6B | 52.31% | |
| 139 | —TCR2 THERAPEUTICS INC | 249,279 | $5.5B | 51.46% | |
| 140 | TOCAEURFORTE BIOSCIENCES INC | 159,664 | $5.5B | 51.16% | |
| 141 | DYNDYNE THERAPEUTICS INC | 350,000 | $5.4B | 50.83% | |
| 142 | INNVINNOVAGE HLDG CORP | 200,000 | $5.2B | 48.23% | |
| 143 | ADAGADAGENE INC | 275,000 | $4.9B | 46.15% | |
| 144 | —LONGBOARD PHARMACEUTICALS IN | 300,000 | $4.9B | 45.95% | |
| 145 | —STRONGBRIDGE BIOPHARMA PLC | 1,744,669 | $4.8B | 45.02% | |
| 146 | CMPSCOMPASS PATHWAYS PLC | 127,816 | $4.7B | 44.00% | |
| 147 | —PROMETHEUS BIOSCIENCES INC | 250,000 | $4.6B | 42.68% | |
| 148 | IFRXINFLARX NV | 1,064,118 | $4.2B | 38.80% | |
| 149 | AXSMAXSOME THERAPEUTICS INC | 50,000 | $2.8B | 26.47% | Put |
| 150 | SANASANA BIOTECHNOLOGY INC | 60,000 | $2.0B | 18.78% | |
| 151 | SELBUSDSELECTA BIOSCIENCES INC | 339,169 | $1.5B | 14.35% | |
| 152 | CVM1EURCEL-SCI CORP | 100,000 | $1.5B | 14.22% | Put |
| 153 | —SILVER SPIKE ACQUISITION COR | 150,200 | $1.1B | 9.88% | |
| 154 | NBPI MAB | 18,565 | $900.0M | 8.42% | |
| 155 | —ARYA SCIENCES ACQUISITION CO | 49,375 | $680.0M | 6.36% | |
| 156 | PPBTPURPLE BIOTECH LTD | 31,418 | $130.0M | 1.22% |
PreviousPage 2 of 2